Unknown

Dataset Information

Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.


ABSTRACT:

Background

Knowledge of the COVID-19 epidemic extent and the level of herd immunity is urgently needed to help manage this pandemic.

Methods

We used a panel of 167 samples (77 pre-epidemic and 90 COVID-19 seroconverters) and SARS-CoV1, SARS-CoV2 and MERS-CoV Spike and/or Nucleopcapsid (NC) proteins to develop a high throughput multiplex screening assay to detect IgG antibodies in human plasma. Assay performances were determined by ROC curves analysis. A subset of the COVID-19+ samples (n = 36) were also tested by a commercial NC-based ELISA test and the results compared with those of the novel assay.

Results

On samples collected ≥14 days after symptoms onset, the accuracy of the assay is 100 % (95 % CI: 100-100) for the Spike antigen and 99.9 % (95 % CI:99.7-100) for

SUBMITTER: Ayouba A 

PROVIDER: S-EPMC7308014 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature